查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575307

狗疫苗市场：按疫苗类型、按技术、按最终用户、按分销管道、按应用、按年龄组、按狗大小 - 2025-2030 年全球预测

Dog Vaccines Market by Vaccine Type (Core Vaccines, Non-Core Vaccines), Technology (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), End User, Distribution Channel, Application, Age Group, Dog Size - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年狗疫苗市值为20.5亿美元，预计到2024年将达到22.1亿美元，复合年增长率为8.03%，到2030年预计将达到35.2亿美元。

由于宠物拥有量的增加、动物健康意识的提高以及兽医学的进步，包含针对犬病的预防性医疗解决方案的犬疫苗市场预计将大幅增长。疫苗接种对于预防狂犬病、细小病毒和犬瘟热等疾病至关重要，不仅可以保护您的宠物，还可以保护公众健康。犬疫苗的应用范围从普遍建议的核心疫苗到针对特定地区或狗的生活方式的非核心和专门疫苗。这些疫苗的最终用途广泛在兽医院、宠物医院和流动兽医医院。市场成长受到宠物医疗保健需求增加、疫苗技术进步以及饲主对预防措施兴趣增加等因素的显着影响。在宠物拥有量不断增加的新兴市场以及开发简化疫苗接种流程的组合疫苗方面，机会比比皆是。公司可以透过创新更易于管理的疫苗、提高功效并扩大分销网络来利用这些机会。然而，市场开拓面临疫苗研发高成本、监管复杂、疫苗抗药性、饲主怀疑等挑战。儘管很少见，但副作用也可能限制广泛接受。为了克服这些挑战，企业应专注于强而有力的研发，创新疫苗输送系统并提高疫苗的安全性。市场竞争激烈，主要企业在不断创新，透过多样化的产品系列扩大市场占有率。增加技术集成，例如人工智慧主导的个人化疫苗计划资料分析，为未来探索提供了肥沃的土壤。上市公司也应考虑与政府机构和卫生组织合作，以加强公众信任和监管合规性，并确保犬隻疫苗的接受度和应用呈上升趋势。

主要市场统计
基准年[2023] 20.5亿美元
预测年份 [2024] 22.1亿美元
预测年份 [2030] 35.2亿美元
复合年增长率（%） 8.03%

市场动态：快速发展的犬隻疫苗市场的关键市场洞察

供需的动态交互作用正在改变犬疫苗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 宠物拥有量的增加以及动物健康和疫苗接种意识的提高
    • 支持强制性宠物疫苗接种和动物疾病控制的政府措施和法规
    • 通用感染疾病的兴起以及疫苗在预防中的作用
    • 兽医学的进步和宠物医疗基础设施投资的增加
  • 市场限制因素
    • 缺乏饲主对狗狗疫苗接种重要性的认知与教育
    • 严格的监管要求和犬疫苗漫长的核准流程导致了疫苗的延误。
  • 市场机会
    • 生物技术的进步导致开发出更有效的针对常见犬类疾病的疫苗
    • 加大研发投入，副作用较少的下一代狗疫苗
    • 动物用药品公司与研究机构合作创造创新的疫苗解决方案
  • 市场挑战
    • 应对犬隻疫苗核准和销售监管环境的变化
    • 平衡犬疫苗产业不断上升的研发和生产成本

波特的五力：驾驭狗狗疫苗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解狗狗疫苗市场的外部影响

外部宏观环境因素对狗疫苗市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解犬隻疫苗市场竞争状况

对狗疫苗市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵犬疫苗市场供应商的绩效评估

FPNV定位矩阵是评估狗狗疫苗市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了狗疫苗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对狗疫苗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 宠物数量不断增加，动物健康和疫苗接种意识不断增强
      • 支持宠物疫苗接种要求和动物疾病控制的政府措施和法规
      • 通用感染疾病发生率上升以及疫苗在预防中的作用
      • 兽医学的进步和宠物医疗基础设施投资的增加
    • 抑制因素
      • 宠物饲主缺乏对狗狗疫苗接种重要性的认知与教育
      • 狗疫苗严格的监管要求和漫长的核准流程导致延误
    • 机会
      • 生物技术的进步导致开发出更有效的针对常见犬类疾病的疫苗
      • 加大研发投入，副作用较少的下一代狗疫苗
      • 动物用药品公司与研究机构合作创造创新的疫苗解决方案
    • 任务
      • 应对犬隻疫苗核准和分销不断变化的法规环境
      • 平衡犬疫苗产业不断上升的研究、开发和生产成本
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章以疫苗类型分類的狗狗疫苗市场

  • 核心疫苗
    • 犬腺病毒
    • 犬瘟热病毒
    • 犬小病毒
    • 狂犬病
  • 非核心疫苗
    • 支气管败血博德氏菌
    • 伯氏疏螺旋体
    • 犬钩端螺旋体

第七章狗疫苗市场：依技术分类

  • DNA疫苗
  • 灭活疫苗
  • 减毒活疫苗
  • 重组疫苗

第八章狗疫苗市场：依最终用户分类

  • 动物医院
  • 宠物诊所
  • 调查机构
  • 兽医诊所

第九章狗疫苗市场：依通路分类

  • 网路药房
  • 零售药房
  • 疫苗接种营
  • 兽医诊所和医院

第十章 狗狗疫苗市场：依应用分类

  • 疾病预防
  • 治疗性的

第十一章狗狗疫苗市场：依年龄组

  • 成年狗
  • 小狗
  • 老狗

第十二章以狗体型分類的狗疫苗市场

  • 巨型物种
  • 大狗
  • 中型狗
  • 小狗

第十三章美洲犬疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十四章亚太狗疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十五章 欧洲、中东和非洲狗疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C028B

The Dog Vaccines Market was valued at USD 2.05 billion in 2023, expected to reach USD 2.21 billion in 2024, and is projected to grow at a CAGR of 8.03%, to USD 3.52 billion by 2030.

The market for dog vaccines, which encompasses preventive healthcare solutions targeted at canine diseases, is poised for significant growth due to increased pet ownership, rising awareness of animal health, and advancements in veterinary medicine. Vaccination is essential for preventing diseases like rabies, parvovirus, and distemper, safeguarding not just the pets but also public health. Applications of dog vaccines span core vaccines that are universally recommended to non-core and specialized vaccines intended for specific regions or canine lifestyles. End-use of these vaccines is prevalent in veterinary clinics, pet hospitals, and mobile veterinary units. Market growth is heavily influenced by factors like the escalating demand for pet healthcare, advances in vaccine technology, and increased focus on preventive measures among pet owners. Opportunities abound in developing markets with growing pet ownership and in creating combination vaccines that streamline the vaccination process. Companies can capitalize on these opportunities by innovating easy-to-administer vaccines, enhancing efficacy, and expanding their distribution networks. Nevertheless, the market faces challenges such as high costs associated with vaccine development, regulatory complexities, and occasional vaccine resistance and skepticism among pet owners. Adverse reactions, although rare, can also limit wider acceptance. To navigate these challenges, firms should focus on robust research and development initiatives, aiming at innovations in vaccine delivery systems, and improving vaccine safety profiles. The nature of the market is highly competitive, with continual innovation from key players aiming to expand their share through diversified product portfolios. Increasing technological integration, such as AI-driven data analytics for personalized vaccine schedules, represents fertile ground for future exploration. Companies should also consider collaborations with governmental and health agencies to enhance public trust and regulatory compliance, ensuring an upward trajectory in the acceptance and application of canine vaccines.

KEY MARKET STATISTICS
Base Year [2023] USD 2.05 billion
Estimated Year [2024] USD 2.21 billion
Forecast Year [2030] USD 3.52 billion
CAGR (%) 8.03%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dog Vaccines Market

The Dog Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing pet ownership and rising awareness about animal health and vaccinations
    • Government initiatives and regulations supporting mandatory pet vaccinations and animal disease control
    • Rising incidences of zoonotic diseases and the role of vaccines in prevention
    • Advancements in veterinary medicine and increasing investment in pet healthcare infrastructure
  • Market Restraints
    • Lack of awareness and education among pet owners about the importance of dog vaccination
    • Stringent regulatory requirements and lengthy approval process for dog vaccines causing delays
  • Market Opportunities
    • Advancements in biotechnology leading to development of more effective vaccines for common canine diseases
    • Rising investment in research and development for next-generation dog vaccines with fewer side effects
    • Collaboration between veterinary pharmaceutical companies and research institutions to create innovative vaccine solutions
  • Market Challenges
    • Navigating fluctuating regulatory landscapes for approval and distribution of dog vaccines
    • Balancing the rising costs of research, development, and production in the dog vaccine industry

Porter's Five Forces: A Strategic Tool for Navigating the Dog Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dog Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dog Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dog Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dog Vaccines Market

A detailed market share analysis in the Dog Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dog Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dog Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dog Vaccines Market

A strategic analysis of the Dog Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dog Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aratana Therapeutics, Inc., Bayer Animal Health GmbH, Biogenesis Bago, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Heska Corporation, Hipra, IDEXX Laboratories, Inc., Intas Pharmaceuticals Ltd., Kyoritsu Seiyaku Corporation, Merck & Co., Inc., Merial Ltd., Neogen Corporation, Phibro Animal Health Corporation, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Dog Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Vaccine Type, market is studied across Core Vaccines and Non-Core Vaccines. The Core Vaccines is further studied across Canine Adenovirus, Canine Distemper Virus, Canine Parvovirus, and Rabies. The Non-Core Vaccines is further studied across Bordetella Bronchiseptica, Borrelia Burgdorferi, and Leptospira Canicola.
  • Based on Technology, market is studied across DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, and Recombinant Vaccines.
  • Based on End User, market is studied across Animal Hospitals, Pet Clinics, Research Institutes, and Veterinary Clinics.
  • Based on Distribution Channel, market is studied across Online Pharmacies, Retail Pharmacies, Vaccination Camps, and Veterinary Clinics & Hospitals.
  • Based on Application, market is studied across Disease Prevention and Therapeutic.
  • Based on Age Group, market is studied across Adult Dogs, Puppies, and Senior Dogs.
  • Based on Dog Size, market is studied across Giant Breed, Large Breed, Medium Breed, and Small Breed.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing pet ownership and rising awareness about animal health and vaccinations
      • 5.1.1.2. Government initiatives and regulations supporting mandatory pet vaccinations and animal disease control
      • 5.1.1.3. Rising incidences of zoonotic diseases and the role of vaccines in prevention
      • 5.1.1.4. Advancements in veterinary medicine and increasing investment in pet healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness and education among pet owners about the importance of dog vaccination
      • 5.1.2.2. Stringent regulatory requirements and lengthy approval process for dog vaccines causing delays
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in biotechnology leading to development of more effective vaccines for common canine diseases
      • 5.1.3.2. Rising investment in research and development for next-generation dog vaccines with fewer side effects
      • 5.1.3.3. Collaboration between veterinary pharmaceutical companies and research institutions to create innovative vaccine solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Navigating fluctuating regulatory landscapes for approval and distribution of dog vaccines
      • 5.1.4.2. Balancing the rising costs of research, development, and production in the dog vaccine industry
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dog Vaccines Market, by Vaccine Type

  • 6.1. Introduction
  • 6.2. Core Vaccines
    • 6.2.1. Canine Adenovirus
    • 6.2.2. Canine Distemper Virus
    • 6.2.3. Canine Parvovirus
    • 6.2.4. Rabies
  • 6.3. Non-Core Vaccines
    • 6.3.1. Bordetella Bronchiseptica
    • 6.3.2. Borrelia Burgdorferi
    • 6.3.3. Leptospira Canicola

7. Dog Vaccines Market, by Technology

  • 7.1. Introduction
  • 7.2. DNA Vaccines
  • 7.3. Inactivated Vaccines
  • 7.4. Live Attenuated Vaccines
  • 7.5. Recombinant Vaccines

8. Dog Vaccines Market, by End User

  • 8.1. Introduction
  • 8.2. Animal Hospitals
  • 8.3. Pet Clinics
  • 8.4. Research Institutes
  • 8.5. Veterinary Clinics

9. Dog Vaccines Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Online Pharmacies
  • 9.3. Retail Pharmacies
  • 9.4. Vaccination Camps
  • 9.5. Veterinary Clinics & Hospitals

10. Dog Vaccines Market, by Application

  • 10.1. Introduction
  • 10.2. Disease Prevention
  • 10.3. Therapeutic

11. Dog Vaccines Market, by Age Group

  • 11.1. Introduction
  • 11.2. Adult Dogs
  • 11.3. Puppies
  • 11.4. Senior Dogs

12. Dog Vaccines Market, by Dog Size

  • 12.1. Introduction
  • 12.2. Giant Breed
  • 12.3. Large Breed
  • 12.4. Medium Breed
  • 12.5. Small Breed

13. Americas Dog Vaccines Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Dog Vaccines Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Dog Vaccines Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aratana Therapeutics, Inc.
  • 2. Bayer Animal Health GmbH
  • 3. Biogenesis Bago
  • 4. Boehringer Ingelheim Animal Health
  • 5. Ceva Sante Animale
  • 6. Chanelle Pharma Group
  • 7. Dechra Pharmaceuticals PLC
  • 8. Elanco Animal Health Incorporated
  • 9. Heska Corporation
  • 10. Hipra
  • 11. IDEXX Laboratories, Inc.
  • 12. Intas Pharmaceuticals Ltd.
  • 13. Kyoritsu Seiyaku Corporation
  • 14. Merck & Co., Inc.
  • 15. Merial Ltd.
  • 16. Neogen Corporation
  • 17. Phibro Animal Health Corporation
  • 18. Vetoquinol S.A.
  • 19. Virbac S.A.
  • 20. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. DOG VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. DOG VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DOG VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. DOG VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. DOG VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DOG VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DOG VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DOG VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DOG VACCINES MARKET SIZE, BY CORE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE ADENOVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE DISTEMPER VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DOG VACCINES MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DOG VACCINES MARKET SIZE, BY BORDETELLA BRONCHISEPTICA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DOG VACCINES MARKET SIZE, BY BORRELIA BURGDORFERI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DOG VACCINES MARKET SIZE, BY LEPTOSPIRA CANICOLA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DOG VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DOG VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DOG VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DOG VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DOG VACCINES MARKET SIZE, BY ANIMAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DOG VACCINES MARKET SIZE, BY PET CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DOG VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DOG VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINATION CAMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DOG VACCINES MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DOG VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL DOG VACCINES MARKET SIZE, BY ADULT DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL DOG VACCINES MARKET SIZE, BY PUPPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL DOG VACCINES MARKET SIZE, BY SENIOR DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL DOG VACCINES MARKET SIZE, BY GIANT BREED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL DOG VACCINES MARKET SIZE, BY LARGE BREED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL DOG VACCINES MARKET SIZE, BY MEDIUM BREED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL DOG VACCINES MARKET SIZE, BY SMALL BREED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. TAIWAN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. THAILAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. VIETNAM DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. DENMARK DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. EGYPT DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. FINLAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. FRANCE DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. GERMANY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. ISRAEL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 283. ISRAEL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. ITALY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 292. ITALY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. NETHERLANDS DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 301. NETHERLANDS DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. NIGERIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 310. NIGERIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 318. NORWAY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 319. NORWAY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 327. POLAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 328. POLAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 336. QATAR DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 337. QATAR DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 344. RUSSIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 345. RUSSIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 346. RUSSIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 347. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 348. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 350. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 352. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 353. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 354. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 355. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 356. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 357. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 358. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 359. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 360. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 361. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 362. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 363. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 364. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 365. SPAIN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 366. SPAIN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 367. SPAIN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 368. SPAIN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 369. SPAIN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 370. SPAIN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 371. SPAIN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 372. SPAIN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 373. SPAIN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 374. SWEDEN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 375. SWEDEN DOG VACCINES MARKET SIZE, BY C